WHC is still in active development. Read this to understand our approach.
depiction of UGJMXCAKCUNAIE-UHFFFAOYSA-N.svg
tripsit

gabapentin

Check on tripsit

psychonaut

Gabapentin

Check on psychonaut

isomerdesign

Gabapentin

Check on isomerdesign

pubchem

Gabapentin

Check on pubchem

druglab

Gabapentine

Check on druglab

drugmap

Gabapentin

Check on drugmap

wiki

Gabapentin

Check on wiki

Data

InChI: InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)

Synonyms: HMS2236O03, 1-(Aminomethyl)-cyclohexaneacetic acid,GABAPENTIN [EP MONOGRAPH],SBI-0206904.P001, Novo-Gabapentin, Vultin, Gabapentinum,GABAPENTIN [VANDF],Tocris-0806, Goe-3450,CCG-204671,Serada,6CW7F3G59X,GABAPENTIN [JAN],DTXSID0020074, Apo-Gabapentin, Gabapentin-ratiopharm,Gabapentin (JAN/USP/INN),GABAPENTIN [ORANGE BOOK],GBN,SPBio_002822,1-aminomethyl-1-cyclohexane-acetic acid,Gabapentin, Pharmaceutical Secondary Standard; Certified Reference Material,1-aminomethylcyclohexane acetic acid,CHEBI:42797,EINECS 262-076-3,Neurontin (TN), Gabapentine [INN-French], Aventis brand of gabapentin,NCGC00015466-05,gabapentin,NSC-759254,Gabapentin,GABAPENTIN [INN],BCP25698, 1-(Aminomethyl)cyclohexaneacetic acid,BRN 2359739,GOE 3450,DSSTox_CID_74, Stadapharm brand of gabapentin,Prestwick0_000861,(1-Aminomethyl-cyclohexyl)-acetic acid,Gabapentin-D10,Aclonium, 2-[1-(aminomethyl)cyclohexyl]acetic acid,CHEMBL940,DSSTox_GSID_20074,GABAPENTIN [MART.],Novo-Gabapentine, Parke Davis brand of gabapentin,Neurontin,Cyclohexaneacetic acid, 1-(aminomethyl)-,NCGC00015466-04,1-(Aminomethyl)cyclohexaneacetic acid, Gabapentino,BPBio1_000993,HY-A0057,BSPBio_000901,Gabapentin solution,NCGC00015466-27,neurontin,CARBATIN,Gabapentin-ER, Gabapentin [USAN:INN:BAN],Prestwick3_000861,CI 945, Gabapentin GR,DDS-2003, Gabapentinum [INN-Latin], Pfizer brand of gabapentin,Gralise,NCGC00021545-04,SCHEMBL8343, Pharmascience brand of gabapentin,NCGC00015466-02,C07018,Z336079954,GABAPENTIN [HSDB], DM-5689,SR-01000000019-11, Gabapentine,NCGC00021545-05,Q410352,gabapentin (Neurontin),Gabapentin GR,EN300-52516,60142-96-3,1-(Aminomethyl)-cyclohexaneacetic acid, Gabapentin (Neurontin), GBN,Fanatrex,CCRIS 7210,AM20070538,1-(aminomethyl)cyclohexanacetic acid,GABAPENTIN [USP-RS],1-aminomethyl cyclohexaneacetic acid,2-(1-(aminomethyl)cyclohexyl)acetic acid,Therapentin-90,Vultin,Neuontin,1-Aminomethyl-1cyclohexane-acetic acid,Gabapentine,Acetic acid,2-[1-(aminomethyl)cyclohexyl], Neurontin (TN),Prestwick1_000861,KS-1064,NSC 759254,Lopac0_000582,GABAPENTIN [USP MONOGRAPH],Gabapentinum [INN-Latin], Gabapentin Hexal,GABAPENTIN [EP IMPURITY],Gabapentin, European Pharmacopoeia (EP) Reference Standard,Gabapentino [INN-Spanish], [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID,FT-0626586,1126623-20-8,NCGC00015466-07, Gabapetin, Serada,42G963,NCGC00021545-02,Tox21_110157,[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID,AB07485,Tox21_110157_1,HMS2089J03,NCGC00015466-11,Gabapentin [USAN:USP:INN:BAN],CAS-60142-96-3,Gabapentine [INN-French],GABAPETINE,1-(Aminomethyl)cyclohexaneaceticAcid,Prestwick2_000861,DM-5689,Gabapentin 100 microg/mL in Acetonitrile:Methanol,BBL010794,LP00582,GOE 2450,HMS3261F06,1-(aminomethyl)cyclohexyl-acetic Acid,GABAPENTIN [MI], Apotex brand of gabapentin,MFCD00865286,D00332,BDBM50080153,NCGC00015466-08,SDCCGSBI-0050564.P002, GOE 2450,NCGC00015466-09,ZINC4949,Lopac-G-154,Gabapentino,UNII-6CW7F3G59X, Gabapentin Stada,FT-0668920,HMS2097N03, Gabapen, Warner-Lambert brand of gabapentin,Gabapentinum,NCGC00015466-06, DDS-2003,SR-01000000019, Gabapentino [INN-Spanish],NCGC00016891-01, Hexal brand of gabapentin,MLS000069358,NSC742194, Gabapentinium,SMR000058311,Gabapentin, United States Pharmacopeia (USP) Reference Standard,GTPL5483,HMS1570N03,Z1258578343,DM-1796, DM-1796,GABAPENTIN [USAN],HSDB 7364,AKOS000280865,HMS3650A20,SR-01000000019-6,ACT03340,Gabapen,Gabapentin solution, 10 mg/mL in methanol, ampule of 1 mL, certified reference material,1-amino methyl cyclohexane-acetic acid,G-154,Sefelsa,DSSTox_RID_75350,gabapentina,Gabapentin, solid,STK598009, PMS-Gabapentin,HMS3714N03,Tox21_500582,Gabapentin solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Ratiopharm brand of gabapentin,CS-1545,NCGC00015466-03, Neurontin, G-154,Gabarone,NSC-742194,GABAPENTIN [WHO-DD], Gabapentina,SR-01000000019-2, Gabapentin (JAN/USAN/INN),Go 3450,DB00996,NCGC00015466-01,GABAPENTIN; NEURONTIN,BIDD:GT0656, Gabapentino [Spanish],NSC 742194,Gabapentino [Spanish],Prestwick_151,DTXCID5074,AC-1485,CI-945,Goe-3450,Gralise (TN),NCGC00261267-01,G0318,s2133, Go 3450,2-[1-(aminomethyl)cyclohexyl]acetic acid,gabapentinium,C9H17NO2,Gabapetin,EU-0100582, Novopharm brand of gabapentin,L000733,Neurentin


Estimated data

Solubility: -0.791 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 61.5% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.